Trials / Completed
CompletedNCT05670977
Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women
A Randomized, Double Blind, Controlled Study of Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Guangdong HuaPeptides Biotechnology Co., Ltd. · Industry
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to study the efficacy of collagen supplement on the moisture content and elasticity. 70 participants of 30-50 years old women will be enrolled from two study sites and randomly assigned to use two products (study product plus collagen supplement and placebo product without collagen supplement) for 2 months. Researchers will compare the two groups to validate the assumption that there is significant improvement on skin anti-aging effect for participants using study product plus collagen supplement.
Detailed description
This study is two arms, randomized, double-blind controlled trial. There will be two study sites and 35 eligible participants at each study site will be enrolled with the expectation of having 30 participants completed per study group. Particants will be randomly allocated to use one of the two study products defined in the trial protocol for two months. Up to three study visits will be made by the participant over a 2-month period. All relevant data will be captured and recorded into CTMS (Clinical Trial Management System). The data will be analyzed and reported after the completion of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Study product plus collagen supplement | The participants in this arm will use the assigned product for 2 months, 5g one time, once a day. |
| DIETARY_SUPPLEMENT | Study product without collagen supplement | The participants in this arm will use the assigned product for 2 months, 5g one time, once a day. |
Timeline
- Start date
- 2023-01-16
- Primary completion
- 2023-03-12
- Completion
- 2023-03-31
- First posted
- 2023-01-04
- Last updated
- 2023-04-13
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05670977. Inclusion in this directory is not an endorsement.